Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308217 · ClinicalTrials.gov registry record
Single Ventricle Outcome
A clinical trial of Single-ventricle and Hypoplastic Left Heart Syndrome, sponsored by Emory University.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00308217: Completed study of Single-ventricle and Hypoplastic Left Heart Syndrome, sponsored by Emory University.
NCT00308217 is a study of Single-ventricle and Hypoplastic Left Heart Syndrome that has completed, run by Emory University. The registered enrollment target is 30 participants, below the 85-participant average among 17 other Single-ventricle trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308217, a study of Single-ventricle and Hypoplastic Left Heart Syndrome, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this research proposal is to perform an ongoing single institution prospective clinical trial examining the overall clinical outcome of children with single ventricle physiology.
Conditions Studied
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-06 |
| Est. Completion | 2005-06 |
What the finished NCT00308217 record still lists
NCT00308217 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 85-participant average among 17 other Single-ventricle trials with a reported enrollment target (65% lower).
The record links to 3 conditions, with Single-ventricle appearing as the primary indexed condition, and to 0 interventions.
NCT00308217 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00308217 about?
NCT00308217 is a clinical study titled "Single Ventricle Outcome". The objective of this research proposal is to perform an ongoing single institution prospective clinical trial examining the overall clinical outcome of children with single ventricle physiology.
What is the current status of trial NCT00308217?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-06. Estimated completion is 2005-06.
What conditions does trial NCT00308217 study?
This clinical trial studies the following conditions: Single-ventricle, Hypoplastic Left Heart Syndrome, Heart Disease, Congenital.
Who is sponsoring clinical trial NCT00308217?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00308217 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Single-ventricle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00308217's enrollment target sits among peer trials
30 10th of 17 higher than 8 of 17 other Single-ventricle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Single-ventricle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Re-Energize Fontan
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
RECRUITING
-
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
RECRUITING · NA
-
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia